Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic
NCT ID: NCT05102656
Last Updated: 2025-11-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
107 participants
INTERVENTIONAL
2021-06-02
2027-02-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During an Outpatient Palliative Care Visit
NCT02957565
Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits
NCT03856060
Message 2: The Effect of Message Content and Clinical Outcome on Patient's Perception of Physician Compassion
NCT02498899
Effect of Physician Attire on Patients' Preference of Physician
NCT03168763
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
NCT04988009
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To determine whether patients perceive their healthcare practitioner as more empathetic during an in-person interaction with the practitioner wearing personal protective equipment (PPE), or during a video interaction without the need for PPE.
SECONDARY OBJECTIVES:
I. To assess whether certain physicians perform better with video whereas others perform better in person.
II. To characterize generational differences in patient perception of healthcare practitioner empathy during an in person interaction with the practitioner wearing PPE, or during a video interaction without the need for PPE.
OUTLINE: After initial visit, patients are randomized to 1 of 2 groups.
GROUP A (NO PPE): Patients receive standard of care via video call with treating physician.
GROUP B (WEARING PPE): Patients receive standard of care in-person physician visits.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A (video call)
Patients receive standard of care via video call with treating physician.
Discussion
Physician conversations occur via video call
Questionnaire Administration
Ancillary studies
Group B (in-person)
Patients receive standard of care in-person physician visits.
Best Practice
Physician conversations occur in-person
Questionnaire Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Best Practice
Physician conversations occur in-person
Discussion
Physician conversations occur via video call
Questionnaire Administration
Ancillary studies
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to speak and write in English
* Able to understand and willing to sign a written informed consent document
* Willing and able to complete the study assessment(s)
Exclusion Criteria
* Too ill to participate, in the estimation of the patient's physician
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kumar Alagappan
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M D Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
M.D. Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2021-10960
Identifier Type: REGISTRY
Identifier Source: secondary_id
2020-1298
Identifier Type: OTHER
Identifier Source: secondary_id
2020-1298
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.